Lexaria Bioscience Corp. (NASDAQ: LEXX), Growing its Market Share, One Patent at a Time
Lexaria’s development of its patented DehydraTECH(TM) technology since 2014 has yielded 27 patents in Australia, the United States, the European…
Lexaria’s development of its patented DehydraTECH(TM) technology since 2014 has yielded 27 patents in Australia, the United States, the European…
D-Wave has announced first ever demonstration of large-scale coherence in quantum annealers New research findings open the door to simulations…
Silo Pharma (OTCQB: SILOD), a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that it…
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced that a…
Lexaria Bioscience Corp. (NASDAQ: LEXX) recently provided information to its stakeholders to help them conveniently research and understand different non-affiliated…
Hillcrest (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA), a clean technology company, addresses the design and mechanical challenges faced by manufacturers…
Pharma, biotech, medical device, and health professionals are invited to attend the 2nd Investigator-Initiated Trials Summit on November 2-3, 2022…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced specifications and unveiled details on the FIVE RS…
In recent interview, Stone Douglass, CEO and Chairman of GeoSolar Technologies, discusses how his prior work drove him to lead…
HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack…